Sylte I - Search Results

1

Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors.

Jarończyk M, Wołosewicz K, Gabrielsen M, Nowak G, Kufareva I, Mazurek AP, Ravna AW, Abagyan R, Bojarski AJ, Sylte I, Chilmonczyk Z. Jarończyk M, et al. Among authors: sylte i. Eur J Med Chem. 2012 Mar;49:200-10. doi: 10.1016/j.ejmech.2012.01.012. Epub 2012 Jan 15. Eur J Med Chem. 2012. PMID: 22309909 Free PMC article.

2

The ligand-binding site of buspirone analogues at the 5-HT1A receptor.

Sylte I, Chilmonczyk Z, Dahl SG, Cybulski J, Edvardsen O. Sylte I, et al. J Pharm Pharmacol. 1997 Jul;49(7):698-705. doi: 10.1111/j.2042-7158.1997.tb06095.x. J Pharm Pharmacol. 1997. PMID: 9255714

3

Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes.

Bronowska A, Sylte I, Edvardsen Ø, Østensen R, Leś A, Chilmonczyk Z. Bronowska A, et al. Among authors: sylte i. Acta Pol Pharm. 2000 Nov;57 Suppl:40-5. Acta Pol Pharm. 2000. PMID: 11293260

4

Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors.

Bronowska A, Leś A, Chilmonczyk Z, Filipek S, Edvardsen O, Ostensen R, Sylte I. Bronowska A, et al. Among authors: sylte i. Bioorg Med Chem. 2001 Apr;9(4):881-95. doi: 10.1016/s0968-0896(00)00307-2. Bioorg Med Chem. 2001. PMID: 11354671

5

Molecular model of the Escherichia coli Na1/H1 antiporter NhaA.

Ravna AW, Sylte I, Dahl SG. Ravna AW, et al. Among authors: sylte i. Recept Channels. 2001;7(4):319-28. Recept Channels. 2001. PMID: 11697236

6

Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.

Bronowska A, Chilmonczyk Z, Leś A, Edvardsen O, Ostensen R, Sylte I. Bronowska A, et al. Among authors: sylte i. J Comput Aided Mol Des. 2001 Nov;15(11):1005-23. doi: 10.1023/a:1014856107486. J Comput Aided Mol Des. 2001. PMID: 11989622

7

Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors.

Chilmonczyk Z, Cybulski M, Iskra-Jopa J, Chojnacka-Wójcik E, Tatarczyńska E, Kłodzińska A, Leś A, Bronowska A, Sylte I. Chilmonczyk Z, et al. Among authors: sylte i. Farmaco. 2002 Apr;57(4):285-301. doi: 10.1016/s0014-827x(02)01205-3. Farmaco. 2002. PMID: 11989808

8

Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.

Ravna AW, Sylte I, Dahl SG. Ravna AW, et al. Among authors: sylte i. J Pharmacol Exp Ther. 2003 Oct;307(1):34-41. doi: 10.1124/jpet.103.054593. Epub 2003 Aug 27. J Pharmacol Exp Ther. 2003. PMID: 12944499

9

Molecular model of the neural dopamine transporter.

Ravna AW, Sylte I, Dahl SG. Ravna AW, et al. Among authors: sylte i. J Comput Aided Mol Des. 2003 May-Jun;17(5-6):367-82. doi: 10.1023/a:1026116017725. J Comput Aided Mol Des. 2003. PMID: 14635728

10

Structures and models of transporter proteins.

Dahl SG, Sylte I, Ravna AW. Dahl SG, et al. Among authors: sylte i. J Pharmacol Exp Ther. 2004 Jun;309(3):853-60. doi: 10.1124/jpet.103.059972. Epub 2004 Feb 26. J Pharmacol Exp Ther. 2004. PMID: 14988415 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters